Atherosclerosis - PowerPoint PPT Presentation

About This Presentation
Title:

Atherosclerosis

Description:

Atherosclerosis Anca Bac rea, Alexandru Schiopu Atherosclerosis The term atherosclerosis, which comes from the Greek words atheros (meaning gruel or paste ... – PowerPoint PPT presentation

Number of Views:380
Avg rating:3.0/5.0
Slides: 34
Provided by: UMF
Category:

less

Transcript and Presenter's Notes

Title: Atherosclerosis


1
Atherosclerosis
  • Anca Bacârea, Alexandru Schiopu

2
(No Transcript)
3
Atherosclerosis
  • The term atherosclerosis, which comes from the
    Greek words atheros (meaning gruel or paste)
    and sclerosis (meaning hardness), denotes the
    formation of fibrofatty lesions in the intimal
    lining of the large and medium-size arteries such
    as the aorta and its branches, the coronary
    arteries, and the large vessels that supply the
    brain.
  • Atherosclerosis contributes to more mortality and
    more serious morbidity than any other disorder in
    the western world.

4
Risk Factors
  • The cause or causes of atherosclerosis have not
    been determined with certainty.
  • Epidemiologic studies have identified
    predisposing risk factors
  • Unchangeable risk factors
  • Age
  • Male gender
  • Men are at grater risk than are premenopausal
    women, because of the protective effects of
    natural estrogens.
  • Family history of premature coronary heart
    disease
  • Several genetically determined alterations in
    lipoprotein and cholesterol metabolism have been
    identified.

5
Risk Factors
  • Changeable risk factors life style risk
    factors
  • Hyperlipidemia
  • The presence of hyperlipidemia is the strongest
    risk factor for atherosclerosis in persons
    younger than 45 years of age.
  • Both primary and secondary hyperlipidemia
    increase the risk.
  • Cigarette smoking
  • Hypertension
  • High blood pressure produces mechanical stress on
    the vessel endothelium.
  • It is a major risk factor for atherosclerosis in
    all age groups and may be as important or more
    important than hypercholesterolemia after the age
    of 45 years.
  • Diabetes mellitus
  • Diabetes elevates blood lipid levels and
    otherwise increases the risk of atherosclerosis.
  • Insufficient physical activity
  • A stressful lifestyle
  • Obesity

6
Risk Factors
  • There are a number of other less well-established
    risk factors for atherosclerosis, including
  • High serum homocysteine levels
  • Homocysteine is derived from the metabolism of
    dietary methionine
  • Homocysteine inhibits elements of the
    anticoagulant cascade and is associated with
    endothelial damage.
  • Elevated serum C-reactive protein
  • It may increase the likelihood of thrombus
    formation
  • Inflammation marker
  • Infectious agents
  • The presence of some organisms (Chlamydia
    pneumoniae, herpesvirus hominis, cytomegalovirus)
    in atheromatous lesions has been demonstrated by
    immunocytochemistry, but no cause-and-effect
    relationship has been established.
  • The organisms may play a role in atherosclerotic
    development by initiating and enhancing the
    inflammatory response.

7
Pathology and pathogenesis
  • The lesions associated with atherosclerosis are
    of three types
  • The fatty streak
  • The fibrous atheromatous plaque
  • Complicated lesion
  • The latter two are responsible for the clinically
    significant manifestations of the disease.

8
(No Transcript)
9
Pathology and pathogenesis
  • Fatty streaks are thin, flat yellow intimal
    discolorations that progressively enlarge by
    becoming thicker and slightly elevated as they
    grow in length.
  • They consist of macrophages and smooth muscle
    cells that have become distended with lipid to
    form foam cells.
  • These occurs regardless of geographic setting,
    gender, or race.
  • They increase in number until about age 20 years,
    and then they remain static or regress.
  • There is controversy about whether fatty streaks,
    in and of themselves, are precursors of
    atherosclerotic lesions.

10
Pathology and pathogenesis
  • The fibrous atheromatous plaque is the basic
    lesion of clinical atherosclerosis.
  • It is characterized by the accumulation of
    intracellular and extracellular lipids,
    proliferation of vascular smooth muscle cells,
    and formation of scar tissue.
  • The lesions begin as a elevated thickening of the
    vessel intima with a core of extracellular lipid
    (mainly cholesterol, which usually is complexed
    to proteins) covered by a fibrous cap of
    connective tissue and smooth muscle.
  • As the lesions increase in size, they encroach on
    the lumen of the artery and eventually may
    occlude the vessel or predispose to thrombus
    formation, causing a reduction of blood flow.

11
Pathology and pathogenesis
  • The more advanced complicated lesions are
    characterized by
  • Hemorrhage
  • Ulceration
  • Scar tissue deposits
  • Thrombosis is the most important complication of
    atherosclerosis.
  • It is caused by slowing and turbulence of blood
    flow in the region of the plaque and ulceration
    of the plaque.

12
Mechanisms
  • There is increasing evidence that atherosclerosis
    is at least partially the result of
  • (1) endothelial injury with leukocyte (lymphocyte
    and monocyte) adhesion and platelet adherence
  • (2) smooth muscle cell emigration and
    proliferation
  • (3) lipid engulfment of activated macrophages
  • (4) subsequent development of an atherosclerotic
    plaque with lipid core

13
Mechanisms
  • One hypothesis of plaque formation suggests that
    injury to the endothelial vessel layer is the
    initiating factor in the development of
    atherosclerosis.
  • Possible injurious agents are
  • Products associated with smoking
  • Immune mechanisms
  • Mechanical stress, such as that associated with
    hypertension.
  • Hyperlipidemia, particularly LDL with its high
    cholesterol content, is also believed to play an
    active role in the pathogenesis of the
    atherosclerotic lesion.

14
LDL - cholesterol
  • The LDL is removed from the circulation by either
    LDL receptors or by scavenger cells such as
    monocytes or macrophages.
  • Approximately 70 of LDL is removed by way of the
    LDL receptor dependent pathway. Although LDL
    receptors are widely distributed, approximately
    75 are located on hepatocytes thus the liver
    plays an extremely important role in LDL
    metabolism.
  • Tissues with LDL receptors can control their
    cholesterol intake by adding or removing LDL
    receptors.
  • The scavenger cells, such as the monocytes and
    macrophages, have receptors that bind LDL that
    has been oxidized or chemically modified.
  • The amount of LDL that is removed by the
    scavenger pathway is directly related to the
    plasma cholesterol level. When there is a
    decrease in LDL receptors or when LDL levels
    exceed receptor availability, the amount of LDL
    that is removed by scavenger cells is greatly
    increased.
  • The uptake of LDL by macrophages in the arterial
    wall can result in the accumulation of insoluble
    cholesterol esters, the formation of foam cells,
    and the development of atherosclerosis.

15
Mechanisms
  • One of the earliest responses to elevated
    cholesterol levels is the attachment of monocytes
    to the endothelium.
  • The monocytes emigrate through the cell-to-cell
    attachments of the endothelial layer into the
    subendothelial spaces, where they are transformed
    into macrophages.
  • Activated macrophages release free radicals that
    oxidize LDL.
  • Oxidized LDL is not recognized at the cell
    receptor level and so, it can not be internalized
    and it longer remains into the blood stream.
  • Oxidized LDL is toxic to the endothelium, causing
    endothelial loss and exposure of the
    subendothelial tissue to blood components
  • It has chemotactic effect on lymphocytes and
    monocytes
  • It has chemotactic effect on smooth muscle cells
    from the arterial media and stimulates production
    of MG-CSF, cytokines, adhesion molecules in the
    endothelium
  • It inhibits endothelium derived releasing factor
    (EDRF), favoring vasospasm
  • It stimulates specific immune system (production
    of antibodies against oxidized LDL).

16
Mechanisms
  • Endothelial disruption leads to platelet adhesion
    and aggregation and fibrin deposition.
  • Platelets and activated macrophages release
    various factors that are thought to promote
    growth factors that modulate the proliferation of
    smooth muscle cells and deposition of
    extracellular matrix in the lesions elastin,
    collagen, proteoglycans.
  • Activated macrophages also ingest oxidized LDL to
    become foam cells, which are present in all
    stages of atheroscleroticplaque formation.
  • Lipids released from necrotic foam cells
    accumulate to form the lipid core of unstable
    plaques.
  • Connective tissue synthesis determinates
    stiffness, calcium fixation and further
    ulceration of atheromatous plaque.

17
Glycosylation and atherosclerosis
  • Glycosylation is a process that affects
    lipoproteins, circulating proteins and proteins
    component of the arterial wall.
  • Effects
  • Glycated LDL stimulates platelet aggregation and
    forms covalent bounds with the proteins of the
    arterial wall.
  • Glycated HDL blocks cholesterol efflux from the
    cells.
  • Collagen glycosylation increases arterial wall
    stiffness, activates macrophages and stimulates
    lipoprotein adherence.
  • Glycosylated proteins form circulating antigens
    which generates antibody and circulating immune
    complexes that will lead to other arterial
    lesions.

18
Modern theory of atherosclerosis
  • Multifactor theory
  • Structural and functional injury of vascular
    endothelium
  • Response to injury of immune cells and smooth
    muscle cells
  • The role of lipoproteins in initiation and
    progression of lesions
  • The role of growth factors and cytokines
  • The role of repeated thrombosis in lesions
    progression.

19
Mechanisms
  • As a result of all presented above
    atherosclerosis can be defined as vicious
    inflammatory process.

20
Clinical Manifestations
  • The clinical manifestations of atherosclerosis
    depend on the vessels involved and the extent of
    vessel obstruction.
  • Atherosclerotic lesions produce their effects
    through
  • narrowing of the vessel and production of
    ischemia
  • sudden vessel obstruction caused by plaque
    hemorrhage or rupture
  • thrombosis and formation of emboli resulting from
    damage to the vessel endothelium
  • In larger vessels such as the aorta, the
    important complications are those of thrombus
    formation and weakening of the vessel wall.
  • In medium-size arteries such as the coronary and
    cerebral arteries, ischemia and infarction caused
    by vessel occlusion are more common.
  • Although atherosclerosis can affect any organ or
    tissue, the arteries supplying the heart, brain,
    kidneys, lower extremities, and small intestine
    are most frequently involved.

21
Coronary heart disease
  • The term coronary heart disease (CHD) describes
    heart disease caused by impaired coronary blood
    flow.
  • In most cases, it is caused by atherosclerosis.
  • Diseases of the coronary arteries can cause
  • Angina
  • Myocardial infarction or heart attack
  • Cardiac dysrhythmias
  • Conduction defects
  • Heart failure
  • Sudden death

22
Coronary circulation
  • There are two main coronary arteries, the left
    and the right, which arise from the coronary
    sinus just above the aortic valve.
  • Although there are no connections between the
    large coronary arteries, there are anastomotic
    channels that join the small arteries.
  • The primary factor responsible for perfusion of
    the coronary arteries is the aortic blood
    pressure.
  • Changes in aortic pressure produce parallel
    changes in coronary blood flow.
  • The contracting heart muscle influences its own
    blood supply by compressing the intramyocardial
    and subendocardial blood vessels. As a result,
    blood flow through the subendocardial vessels
    occurs mainly during diastole.
  • Thus, there is increased risk of subendocardial
    ischemia when a rapid heart rate decreases the
    time spent in diastole, and when an elevation in
    diastolic intraventricular pressure is sufficient
    to compress the vessels in the subendocardial
    plexus.

23
Coronary circulation
  • Blood flow usually is regulated by the need of
    the cardiac muscle for oxygen.
  • Even under normal resting conditions, the heart
    extracts and uses 60 to 80 of oxygen in blood
    flowing through the coronary arteries, compared
    with the 25 to 30 extracted by skeletal muscle.
  • Because there is little oxygen reserve in the
    blood, myocardial ischemia develops when the
    coronary arteries are unable to dilate and
    increase blood flow during periods of increased
    activity or stress.
  • Heart muscle relies primarily on fatty acids and
    aerobic metabolism to meet its energy needs.
    Although the heart can engage in anaerobic
    metabolism, this process relies on the continuous
    delivery of glucose and results in the formation
    of large amounts of lactic acid.

24
Pathogenesis of coronary heart disease (CHD)
  • Atherosclerosis is by far the most common cause
    of CHD, and atherosclerotic plaque disruption the
    most frequent cause of myocardial infarction and
    sudden death.
  • More than 90 of persons with CHD have coronary
    atherosclerosis.
  • Most, if not all, have one or more lesions
    causing at least 75 reduction in cross-sectional
    area, the point at which augmented blood flow
    provided by compensatory vasodilation no longer
    is able to assure even moderate increases in
    metabolic demand.
  • There are two types of atherosclerotic lesions
  • the fixed or stable plaque, which obstructs blood
    flow
  • commonly implicated in chronic ischemic heart
    disease stable angina, variant or vasospastic
    angina, and silent myocardial ischemia
  • the unstable or vulnerable plaque, which can
    rupture and cause platelet adhesion and thrombus
    formation
  • commonly implicated in unstable angina and
    myocardial infarction.

25
Pathogenesis of coronary heart disease (CHD)
  • Plaque disruption may occur with or without
    thrombosis.
  • Platelets play a major role in linking plaque
    disruption to acute CHD.
  • As a part of the response to plaque disruption,
    platelets aggregate and release substances that
    further propagate platelet aggregation,
    vasoconstriction, and thrombus formation.
  • Because of the role that platelets play in the
    pathogenesis of CHD, antiplatelet drugs (e.g.,
    low-dose aspirin) are frequently used for
    preventing heart attack.

26
Pathogenesis of coronary heart disease (CHD)
27
Myocardial infarction
  • Acute myocardial infarction (AMI), also known as
    a heart attack, is characterized by the ischemic
    death of myocardial tissue associated with
    atherosclerotic disease of the coronary arteries.
  • Diagnosis
  • 1. Pain
  • The pain typically is severe and crushing, often
    described as being constricting, suffocating. It
    usually is substernal, radiating to the left arm,
    neck, or jaw, although it may be experienced in
    other areas of the chest.
  • Gastrointestinal complaints are common. There may
    be a sensation of epigastric distress nausea and
    vomiting may occur.
  • 2. ECG
  • Elevation of the ST segment usually indicates
    acute myocardial injury.
  • When the ST segment is elevated without
    associated Q waves, it is called a nonQ-wave
    infarction. A nonQ-wave infarction usually
    represents a small infarct that may evolve into a
    larger infarct.
  • 3. Enzymes

28
Enzymes
  • Myoglobin is an oxygen-carrying protein, similar
    to hemoglobin, that is normally present in
    cardiac and skeletal muscle. It is a small
    molecule that is released quickly from infarcted
    myocardial tissue and becomes elevated within 1
    hour after myocardial cell death, with peak
    levels reached within 4 to 8 hours. It rapidly
    eliminates through urine (low molecular weight).
    Because myoglobin is present in both cardiac and
    skeletal muscle, it is not cardiac specific.
  • Creatine kinase (CK), formerly called creatinine
    phosphokinase, is an intracellular enzyme found
    in muscle cells. Muscles, including cardiac
    muscle, use ATP as their energy source. Creatine,
    which serves as a storage form of energy in
    muscle, uses CK to convert ADP to ATP. CK exceeds
    normal range within 4 to 8 hours of myocardial
    injury and declines to normal within 2 to 3 days.
    There are three isoenzymes of CK, with the MB
    isoenzyme (CK-MB) being highly specific for
    injury to myocardial tissue.

29
Enzymes
  • The troponin complex consists of three subunits
    (i.e., troponin C, troponin I, and troponin T)
    that regulate calcium-mediated contractile
    process in striated muscle. These subunits are
    released during myocardial infarction. Cardiac
    muscle forms of both troponin T and troponin I
    are used in diagnosis of myocardial infarction.
    Troponin I (and troponin T not shown) rises more
    slowly than myoglobin and may be useful for
    diagnosis of infarction, even up to 3 to 4 days
    after the event. It is thought that cardiac
    troponin assays are more capable of detecting
    episodes of myocardial infarction in which cell
    damage is below that detected by CK-MB level.

30
Myocardial infarction
31
Effects of AMI
  • The principal biochemical consequence of AMI is
    the conversion from aerobic to anaerobic
    metabolism with inadequate production of energy
    to sustain normal myocardial function.
  • The ischemic area ceases to function within a
    matter of minutes, and irreversible myocardial
    cell damage occurs after 20 to 40 minutes of
    severe ischemia.
  • The term reperfusion refers to re-establishment
    of blood flow through use of thrombolytic therapy
    or revascularization procedures.
  • Early reperfusion (within 15 to 20 minutes) after
    onset of ischemia can prevent necrosis.
  • Reperfusion after a longer interval can salvage
    some of the myocardial cells that would have died
    because of longer periods of ischemia.

32
Peripheral arterial disease (PAD)
  • PAD refers to the obstruction of large arteries
    not within the coronary, aortic arch vasculature,
    or brain.
  • It can result from atherosclerosis, inflammatory
    processes leading to stenosis, an embolism, or
    thrombus formation.
  • It causes either acute or chronic ischemia (lack
    of blood supply).
  • Often PAD is a term used to refer to
    atherosclerotic blockages found in the lower
    extremity.
  • Risk factors contributing to PAD are the same as
    those for atherosclerosis.
  • Risk of PAD also increases in individuals who are
    over the age of 50, male, obese, or with a family
    history of vascular disease, heart attack, or
    stroke.

33
Peripheral arterial disease (PAD)
  • About 20 of patients with mild PAD may be
    asymptomatic
  • Symptoms include
  • Claudication - pain, weakness, numbness, or
    cramping in muscles due to decreased blood flow
  • Sores, wounds, or ulcers that heal slowly or not
    at all
  • Noticeable change in color (blueness or paleness)
    or temperature (coolness) when compared to the
    other limb
  • Diminished hair and nail growth on affected limb
    and digits.
Write a Comment
User Comments (0)
About PowerShow.com